Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine

COVID-19 vaccination seems to be the most pertinent pharmacologic public health measure to control the pandemic. Reactogenicity symptoms were frequent in vaccine recipients mostly mild to moderate and commonly reported after the second dose. However, there is a lack of data in patients with a previous diagnosis of Covid-19.

Mots clés

COVID-19 vaccine COVID-2019 Pfizer-BioNTech COVID-19 vaccine SARS-CoV 2 Side effects Vaccine reactogenicity

Domaines

Médecine humaine et pathologie Microbiologie et Parasitologie

Fichier principal

S0264410X21009257.pdf (238.46 Ko)

Origine	Fichiers produits par l'(les) auteur(s)

Accord Elsevier CCSD : Connectez-vous pour contacter le contributeur

https://hal.science/hal-03364254

Soumis le : mardi 22 août 2023-09:09:09

Dernière modification le : lundi 4 mars 2024-10:42:22

Archivage à long terme le : samedi 25 novembre 2023-11:55:32

Dates et versions

hal-03364254 , version 1 (22-08-2023)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

HAL Id : hal-03364254 , version 1
DOI : 10.1016/j.vaccine.2021.07.047
PII : S0264-410X(21)00925-7
PUBMED : 34332800
PUBMEDCENTRAL : PMC8295016

Citer

Noémie Tissot, Anne-Sophie Brunel, Fabienne Bozon, Béatrice Rosolen, Catherine Chirouze, et al.. Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine. Vaccine, 2021, 39 (36), pp.5087-5090. ⟨10.1016/j.vaccine.2021.07.047⟩. ⟨hal-03364254⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-FCOMTE CHRONO-ENVIRONNEMENT INEE-CNRS

32 Consultations

13 Téléchargements